Amylyx Pharmaceuticals (AMLX) Enterprise Value (2022 - 2026)
Amylyx Pharmaceuticals' Enterprise Value was $1.75 billion in Q2 2026, up 347.8% from $390.67 million a year earlier and up 38.5% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Enterprise Value (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amylyx Pharmaceuticals' Enterprise Value was $808.68 million through Jun 30, 2026; for FY2025, it came in at $1.01 billion.
- Enterprise Value shows a three-year compound annual growth rate of -21.8% (FY2022 to FY2025).
- In earlier years, Enterprise Value was $82.92 million in FY2024 (-86.7%), $625.29 million in FY2023 (-70.4%) and $2.11 billion in FY2022.
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q4 2022.
- Per Business Quant data, AMLX's Enterprise Value in the three quarters before Q2 2026 was $1.26 billion (Q1 2026), $1.01 billion (Q4 2025) and $1.15 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Amylyx Pharmaceuticals | 3.32 Bn | 3.32 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Bn |
| Mar 31, 2026 | 1.26 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 1.15 Bn |
| Jun 30, 2025 | 390.67 Mn |
| Mar 31, 2025 | 111.28 Mn |
| Dec 31, 2024 | 82.92 Mn |
| Sep 30, 2024 | -12.31 Mn |
| Jun 30, 2024 | -180.46 Mn |
| Mar 31, 2024 | -180.24 Mn |
| Dec 31, 2023 | 625.29 Mn |
| Sep 30, 2023 | 880.97 Mn |
| Jun 30, 2023 | 1.10 Bn |
| Mar 31, 2023 | 1.62 Bn |
| Dec 31, 2022 | 2.11 Bn |
| Sep 30, 2022 | 1.49 Bn |
| Jun 30, 2022 | 920.67 Mn |
| Mar 31, 2022 | 488.35 Mn |
API Access
Amylyx Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();